A Safety and Efficacy Study of a Bowel Cleansing Preparation

A Safety and Efficacy Study of a Bowel Cleansing Preparation (BLI800) in Pediatric Subjects Undergoing Colonoscopy

November 22, 2017

  • Clinical Trial Information

    Trial Contact: Parrimon, Yozandra; Tilme, Linda

    Trial Phone: 321.841.1361 ; 321.843.5278

  • IRB No: 16.092.07

    Protocol Abbrev: BLI800-502 BowelPrep

    Principal Investigator: Devendra I Mehta, MD

    Sub Investigators: Bornstein, Jeffrey MD; Horvath, Karoly MD; Jackson, Teri ARNP; Safder, Shaista MD; Raijer, Carolina, ARNP; Smadi, Yamen MD

    Phase: Drug: Phase III

    Age Group: Pediatric

    Secondary Protocol No: BLI800-502

    Treatment: BLI800; NuLYTELY

    Applicable Disease Sites: Bowel Preparation, GI, colonoscopy

    Therapies Involved: Medication

    ClinicalTrials.gov ID: NCT02819323

  • Objective

    2. Describe the general characteristics (demographic, anthropometric and clinical measures) of patients presenting for weight management and predictors (program format, provider type, and patient-level factors) of program response.

  • Key Eligibility

    1. Male or female between the ages of 12 to 16 years old.
    2. Undergoing colonoscopy for routinely accepted indications.